MetLife, Inc. (MET): Price and Financial Metrics
Today's Latest Price: $39.07 USD
Oct 19 6:30pm Add MET to Watchlist Sign Up
MET Stock Summary MET has a higher market value than 94.33% of US stocks; more precisely, its current market capitalization is $35,652,981,625. With a price/earnings ratio of 5.01, Metlife Inc P/E ratio is greater than that of about merely 5.05% of stocks in our set with positive earnings. Of note is the ratio of Metlife Inc's sales and general administrative expense to its total operating expenses; only 0.34% of US stocks have a lower such ratio. Stocks with similar financial metrics, market capitalization, and price volatility to Metlife Inc are ORAN, RCI, COP, EOG, and SLB. MET's SEC filings can be seen here. And to visit Metlife Inc's official web site, go to www.metlife.com.
MET Price/Volume Stats
MetLife, Inc. (MET) Company Bio
Metlife Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company was founded in 1863 and is based in New York, New York.
MET Latest News Stream
All News Types
Acquisition Barron's Buyback Commentary Corp. News Cramer Dividend Downgrade Earnings Guidance Down Insider Buying New Coverage (Bearish) New Coverage (Bullish) New Coverage (Neutral) PT Lowered PT Raised PT Set (Bearish) PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Resumes Coverage (Neutral) Spin-off Upgrade
Loading, please wait...
Latest MET News From Around the Web
Below are the latest news stories about Metlife Inc that investors may wish to consider to help them evaluate MET as an investment opportunity.
The way the San Francisco 49ers played, missing quarterback Jimmy Garoppolo and a slew of starters wasn't an issue against the woeful and winless New York Giants.
MetLife ([[MET]] +1.8%) reportedly started a sale process for its P&C business with a potential price of $3B-$4B, a price that "seems reasonable for a personal lines business with a solid track record," say KBW analysts Ryan Krueger and Meyer Shields in a note released late Thursday.Refers to article in...
The following slide deck was published by MetLife, Inc. in conjunction with this event....
Metlife will acquire vision benefits company Versant Health in an all-cash transaction
NEW YORK--(BUSINESS WIRE)--METLIFE TO ACQUIRE VERSANT HEALTH, OWNER OF DAVIS VISION AND SUPERIOR VISION
Read More 'MET' Stories Here
MET Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.8455 seconds.